Yale Cancer Center Precision Medicine Tumor Board: one tumour, multiple targets
Year: 2018
Type: article
Study design: Case Report
Source: The Lancet Oncology
Institution: Yale University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Eli Lilly and Company, Genentech
OpenAlex ID: W2902019952
